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PP-212 Rapid detection of Mycobacterium tuberculosis
complex in spinal aspirate from cases of Pott’s
spine disease
S.G. Babu1 *, M. Kumar1, R. Kumar2, V.L. Nag3, U. Singh4,
T.N. Dhole3. 1Babasaheb Bhimrao Ambedkar University,
Lucknow, India, 2Department of Neurosurgery, Sanjay
Gandhi Postgraduate Institute of Medical Sciences,
Lucknow, India, 3Department of Microbiology, Sanjay
Gandhi Postgraduate Institute of Medical Sciences,
Lucknow, India, 4Department of Biostatistics, Sanjay
Gandhi Postgraduate Institute of Medical Sciences,
Lucknow, India
Objectives: Pott’s disease causing paraplegia is common and
increasing its prevalence in developing countries. It has poor
prognosis due to late diagnosis. Therefore, rapid diagnosis
is essential to decrease the morbidity and mortality of
this disease. Conventional laboratory diagnosing methods
are time consuming and also suffers from low sensitivity.
The present study was undertaken with an aim to assess
the applicability of rapid methods such as PCR with the
traditional BACTEC culture and Microscopic detection of
Mycobacterium complex (MTBC) in spinal specimens.
Methods: Sixty two samples of suspected cases of Pott’s
disease were included in this study. They were processed
for Ziehl-Neelsen staining for acid fast bacilli (AFB) and
BACTEC culture for M. tuberculosis. Further, they were also
processed for PCR ampliﬁcation of insertion element IS6110
of M. tuberculosis complex. The Sensitivity, speciﬁcity and
positive-negative predictive value were assessed and also
Kappa coefﬁcient calculated for agreement culture between
these tests.
Results: Out of 62 suspected Pott’s spine cases 34 were male
and 28 were female ranging the age between 12 to 78 yrs.
As all these samples were tested against Mycobacterium
by the different methods and ZN staining detected AFB
in 19 (30.6%); BACTEC culture was positive for MTBC in
27 (43.5%) and PCR detected MTBC in 33 (53.2%) of the above
tested cases. Considering BACTEC culture as gold standard,
the sensitivity, speciﬁcity, positive and negative predictive
values (PPV&NPV) were 96%, 80%, 79%, 97% correspondingly
for the PCR test and for ZN staining they were 52%, 91%, 82%
and 71% respectively. Kappa agreement between cultures
with ZN and culture with PCR is k 0.51 & 0.75 respectively.
Conclusion: PCR results showed a good agreement with
BACTEC culture. Further, the results also suggests that PCR is
useful for early diagnosis of tuberculosis in spinal samples.
PP-213 Identiﬁcation of non-tuberculous mycobacteria:
utility of the GenoType Mycobacterium CM assay
compared with colloidal gold method and 16Sa
rRNA gene sequencing
Y.J. Shen1, J.L. Jin1, W.H. Zhang1. 1Department of
infectious disease, Huashan Hospital, Fudan University,
China
Background: Non-tuberculous mycobacteria (NTM) causing
clinical disease have become increasingly common and
more diverse. A new reverse line probe assay, GenoType
Mycobacterium CM (Hain Lifescience), was evaluated for
the ability to differentiate mycobacterial species.
Methods: Culture positive isolates were analyzed using
colloidal gold method and 16S rRNA gene PCR and
sequencing. A total of 18 clinical isolates were identiﬁed.
Result: According to the result of the 16S rRNA sequencing,
2 strains (11.1%) were identiﬁed as Mycobacterium
tuberculosis (MTB). Concordant results between the
GenoType Mycobacterium assay and 16S rRNA sequencing
were obtained in 18/18 clinical isolates (100%). But for
colloidal gold method, 1 Non-tuberculosis Mycobacterium
(NTM) strain was classiﬁed as MTB while 1 MTB strain was
classiﬁed as NTM and the total concordant rate was 88.9%.
Conclusion: In conclusion, the GenoType Mycobacterium
CM assay represents a useful tool to rapidly identify
mycobacterial clinical isolates. The molecular system is
as rapid and reliable as the 16S rRNA sequencing, but more
accurate than the colloidal gold method.
PP-214 Chemotherapeutic implications of thioridazine
against active and latent tuberculosis
A. Singh1, S. Sharma1 *. 1Department of Biochemistry,
PGIMER, Chandigarh, Inda
Background: Current chemotherapy of tuberculosis (TB)
has been rendered quite ineffective by the emergence
of resistant strains worldwide and ineffective strategies
against latent tuberculosis infection. A rational approach
is to develop/improve existing drugs to be used as
new antitubercular agents. Phenothiazines, particularly
thioridazine has documented in vitro activity against various
strains of M. tuberculosis. Further, it has been shown that
Phenothiazine analogues speciﬁcally inhibit type-II NADH
dehydrogenase and may be effective in preventing the
transition of M. tuberculosis from actively growing to non-
replicating stage during chronic infections. The present
study was designed to evaluate their in vitro and in vivo
killing efﬁcacies against active and latent TB.
Methods: Thioridazine was evaluated for its in vitro
and in vivo inhibitory activity against active and latent
M. tuberculosis.
Results: Thioridazine was found to be effective against
M. tuberculosis with a MIC of 10 mg/ml. Thioridazine showed
synergistic activity with front-line antituberculosis drugs
Rifampicin and Isoniazid even at sub-MIC concentrations.
In vivo studies conﬁrmed the accumulation of Thioridazine
in the alveolar macrophages. When Thioridazine was used
in combination with Rifampicin and Isoniazid in a short-
course chemotherapy model of experimental tuberculosis,
it showed more potent activity than a combination of
Rifampicin and Isoniazid. Similar results were observed
in 6-week extended chemotherapy for experimental
tuberculosis, when thioridazine was used as an adjunct
drug in the standard regimen. Thioridazine also showed
promising activity against in vitro and in vivo models of
latent tuberculosis, where it was able to kill dormant/latent
bacilli effectively.
Conclusions: Thioridazine has shown potential in vitro and
in vivo activity against both active and latent tuberculosis.
Our observations clearly show that phenothiazines,
especially thioridazine may be considered as an adjunct
drug for improving the chemotherapy of tuberculosis.
PP-215 Effectiveness and safety of intrapleural tissue
plasminogen activator in the prevention of
pleural thickening and loculated effusions by
infective pleurisy
J.-C. Lin1, C.-R. Zhang1 *, W.-M. Xu1, M. Li1, W.-L. Cui1.
1Huang Pu Hospital of the First Afﬁliated Hospital, Sun
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Objective: To explore the clinical curative effect of
intrapleural injection of Tissue Plasminogen Activator (t-PA)
in the prevention of pleural loculated effusions by infective
pleurisy.
Methods: 32 patients with loculated effusions were
randomized into 2 groups, intrapleural Tissue Plasminogen
Activator therapy group and conventional group (control
group). The patients in therapy group were injected
with t-PA 10mg and saline 50ml intrapleurally after each
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thoracocentesis, other therapies were similar to control
group. The clinical curative effect and adverse effect were
observed for the two groups.
Results: (1) The mean volume of ﬂuid drained was
1100±450ml and 630±105ml. The mean time of admission
was 14±5.5 d and 20±6.7 d. The incidence of pleural
adhesion and loculation was 5 cases (33.3%) and 12 cases
(70.6%) after 3 months in the therapy group and the control
group respectively. There were signiﬁcant difference for
mean volume of ﬂuid drained, mean time of admission and
the incidence of pleural adhesion and loculation between
the therapy group and control group (P < 0.05). (2) The mean
number of ﬂuid drained and pulmonary function indexes was
signiﬁcant difference between the two groups (P < 0.05).
There was no serious adverse effect for the two groups.
Conclusion: Intrapleural injection of t-PA can evidently
increase the volume of pleural effusion drained, prevent the
incidence of pleural adhesion and loculation, and improve
the lung function.
PP-216 Analysis of features of chest X-ray and
surveillance of blood glucose level on
diabetes mellitus complicated with pulmonary
tuberculosis
C.-R. Zhang1 *, X.-Y. Liu1, H. Zhou1, W.-L. Cui1, W.-M. Xu1.
1Huang Pu Hospital of the First Afﬁliated Hospital, Sun
Yat-sen University, Guangzhou 510700, China
Objective: To observe the features of chest X-ray and the
control of blood glucose on diabetic patients complicated
with pulmonary tuberculosis.
Methods: The clinical data of a total of 316 diabetes
mellitus patients with pulmonary tuberculosis were made a
retrospectively investigation from Jan 1998 to Dec 2007.
Results: Chest X-Ray examination manifested mass
conﬂuence or plaque tuberculose focus, there were
bronchidissemination focus around the cavity. The GHBA1c,
C peptide and the control of blood glucose level
were 10.74±2.95%, 0.56±0.38 nmol/L, 13.11±5.63mmol/L,
9.32±2.9%, 0.60±0.3 nmol/L and 10.61±2.9mmol/L in the
diabetic patients with and without pulmonary tuberculosis
respectively. There were signiﬁcant difference for GHBA1c
and blood glucose level between the two groups (P < 0.05).
Conclusions: The characteristic changes of the cavity and
surveillance of blood glucose level are helpful to diagnosis
of pulmonary tuberculosis in the patients with diabetes
mellitus.
PP-217 Treatment for abdominal tuberculosis caused
adhesive small bowel obstruction using ileus
tube combined somatostatin
X.Y. Cao1, J. Jiang2 *, M.-S. Jin3, L. He1, Q. Wang1, J. Suo1.
1Department of Gastrointestinal Surgery, First Hospital of
Jilin University, China, 2Division of Clinical Epidemiology,
First Hospital of Jilin University, China, 3Division of
Pathology, First Hospital of Jilin University, China
Background: Abdominal tuberculosis was an important
cause for intestinal obstruction in many countries. The
aim of this study was to evaluate the efﬁcacy and safety
of ileus tube and somatostatin for abdominal tuberculosis
caused adhesive small intestinal bowel obstruction in a
single center study.
Methods: Between January 2002 and April 2011, Fifty-
one patients diagnosed with abdominal tuberculosis caused
adhesive intestinal bowel obstruction were enrolled in
the study. They were randomly divided into two groups:
somatostatin (0.6mg/day) + ileus tube group (Group A,
n = 24), and nasogastric tube group (Group B, n = 27). All
cases received conventional treatment, including fasting,
maintaining electrolyte and acid-base balance, enteral and
parenteral nutrition support, conventional antitubercular
chemotherapy and antibiotics treatment.
Result: Group A had a quick recovery of ﬂatus and
stool compared with Group B, [(4.5±1.9) vs (7.8±1.7)
d] (P< 0.05). Abdominal pain and abdominal distension
recovered faster [(3.6±1.5) vs (8.4±2.2) day] in the group A
compared with the group B. The rate of intestinal operation
in Group A was 4.2%, which was signiﬁcantly less than the
25.9% in Group B (P< 0.05).
Conclusion: Abdominal tuberculosis is an important and
increasingly common cause of acute bowel obstruction. The
high improvement rate in abdominal symptoms suggested
the efﬁcacy of somatostatin and ileus tube in patients
with intestinal bowel obstruction caused by abdominal
tuberculosis. The application of somatostatin combined
with ileus tube can improve the symptoms of tuberculosis
adhesive intestinal obstruction and decrease the rate of
operation. Aggressive surgery should be avoided and initial
surgical intervention should be limited to tissue or ﬂuid
sampling.
PP-218 The interferon-gamma release assay used in
patients with Fever of Unknown Origin
Y. Wang1, K.Y. Zhang1, H.Y. Chen1, Y.X. Li1, X.Y. Yang1,
W.G. Bao1, F. Wang1 *. 1The infectious disease department
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Background: T-SPOT.TB is an interferon-gamma release
assay to detect T-cell response to early secreting antigen
target 6 and culture ﬁltrate protein 10 peptides by enzyme-
linked immunospot assay for tuberculosis diagnosis. This
assay has been licensed for in-vitro diagnosis in Europe, the
United States and China.
Methods: We enrolled 48 patients in the 1st hospital
of Jilin University with fever of unknown origin whose
blood culture and sputum culture results were negtive and
hematological disease and connective tissue disease were
eliminated. Totally 48 patients took T-SPOT.TB assay to
detect early secreting antigen target 6 or culture ﬁltrate
protein 10 peptides-speciﬁc T cells in the peripheral blood
mononuclear cells (PBMCs). The patiens also took tuberculin
skin test (TST). We use T-SPOT.TB produced by Oxford
Immunotec Ltd..
Result: The results of T-SPOT.TB of 25 patients were
positive. 19 of them receicved anti-tuberculosis therapies
and improved. 6 patients’s body temporature decreased to
the normal level after being treated with proper antibiotics.
The TST results of 13 patients were positive. One patient
was empirically treated with antibiotics ﬁrst but failed. And
then the patient was suspected to be with tuberculosis
by hydrothorax tests and received experimental anti-
tuberculosis therapis and recoverd soon. 20 patients were
diagnosed as active tuberculosis. 6 patients were considered
as latent tuberculosis. The sensitivity of T-SPOT.TB is 95%
and the speciﬁcity of T-SPOT.TB is 100%. The sensitivity
of TST is 40% and the speciﬁcity of TST is 61.5%. Most
patients with latent tuberculosis refused the treatment of
anti-tuberculosis.
Conclusion: The infection rate is high in China. Tuberculosis
is an important etiology of fever of unknown origin.
Interferon-gamma release assay has much higher sensitivity
and speciﬁcity than TST.
